Firms like Indian Immunologicals (IIL) and Wockhardt are in talks for manufacturing tie-ups with US vaccine major Moderna for its mRNA platform-based vaccine, sources said. “There are two specific steps in vaccine manufacturing. One is making the drug substance, and another is filling the drug substance in vials.

If a foreign player supplies the drug substance, then several Indian players have fill-finish capabilities to make the final product. This would typically enhance the vaccine maker’s capacity and reach in this market,” said a person close to the development. …

Source:
https://www.business-standard.com/article/companies/wockhardt-iil-discuss-manufacturing-tie-up-with-us-vaccine-major-moderna-121012100023_1.html

Similar articles:

  1. Oxford preparing COVID-19 vaccine versions to fight virus variants: Report [https://www.udayavani.com/english-news/oxford-preparing-covid-19-vaccine-versions-to-fight-virus-variants-report]

Leave a Reply

Your email address will not be published. Required fields are marked *